FARMINGDALE, NY—July 1, 2010—PEDiNOL Pharmacal Inc. is proud to unveil its newest line of products, PEDiNOL’s Hydro ARMOR Ag Professional Blister Care dressings. These dressings are specially made with a proprietary hydrocolloid adhesive formulation. 

PEDiNOL’s Hydro ARMOR Ag, sterile and latex free dressings, are designed to be flexible and conformable, easily fitting difficult areas of the feet, heels and toes. They provide a waterproof, mechanical barrier to external contaminants, which, if left untreated, can cause infection. Once applied over blisters, the dressings create a moist wound environment which facilitates the healing process of blisters better than conventional bandages. The dressings, which may be left on for up to 7 days, provides around the clock blister care and skin protection.

 “Although blisters may not be the primary reason for a patient to visit their podiatrist, they do often come up in conversation as a secondary ailment”, states Gary Strauss, CEO of PEDiNOL. “Providing specialized products for podiatrists is what our company prides itself on. PEDiNOL’s Hydro ARMOR Ag dressings offer an effective blister care solution which both podiatrists, and their patients, will benefit from.”       

PEDiNOL’s Hydro ARMOR Ag dressings are designed to be patient friendly, allowing podiatrists to provide personalized care for their patient’s blisters. Podiatrists can mix and match the amount of toe and heel dressings they recommend to continue patient care and therapy, according to their patient’s individual needs. Toe and heel dressings will be available for continued patient care exclusively through their foot doctor.

PEDiNOL’s Hydro ARMOR Ag Blister Care Kit is specifically designed for continued at-home patient care and contains 6 heel dressings and 4 toe dressings. PEDiNOL’s Nourishing Cream, which is formulated with Vitamin E and A to help promote healthy skin, is also provided in the kit. Podiatrists may purchase the Blister Care Kit online at www.pedinol.com and direct patients to do the same.

Richard Strauss, R.Ph., President of PEDiNOL, is very confident in the new blister care line stating, “I'm certain customers will be impressed with both the functionality and efficacy of PEDiNOL’s Hydro ARMOR Ag dressings. Podiatrists are seeing the value of continuing patient care with this product and the positive effect it has on patient convenience and satisfaction.”

PEDiNOL’s Hydro ARMOR Ag Dressings are available exclusively from PEDiNOL Pharmacal, Inc. Podiatrists may place an order or learn more about PEDiNOL’s Hydro ARMOR Ag Professional Blister Care Product Line by calling 1-800-PEDiNOL or contacting their PEDiNOL sales representative.

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY and was founded in the 1920’s by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon® (fenoprofen calcium 200 mg and 400 mg capsules) and Fungoid® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.

FARMINGDALE, NY—January 22, 2010—PEDiNOL Pharmacal Inc. has introduced a new product logo in anticipation of their upcoming launch of Nalfon 400 mg. The original Nalfon logo was developed by PEDiNOL in 2005. The new logo, which will be featured on Nalfon 400mg advertisements and sample packaging, is an updated version of the original logo intended to reflect the company’s commitment to innovation and progress. 

Prompted by feedback from their patients, many podiatrists requested the development of a Nalfon 400 mg capsule. “The development of Nalfon 400 mg is a direct result of PEDiNOL’s continual dedication to our customer’s wants and needs” stated Richard Strauss, R.Ph., President of PEDiNOL.

The 3-D blue and green symbols on the new product logo illustrate the signature Nalfon colors.  Chief Executive Officer Gary Strauss states, “The development of Nalfon 400mg reflects who we are, the customers that drive our business and the passion that differentiates us in the area of podiatric pharmaceuticals”.

Please see a sales representative or www.nalfon.com for full prescribing information.

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY, and was founded in 1925 by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon^® 200 (fenoprofen calcium 200 mg capsules) and Fungoid^® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.

About Nalfon:

Nalfon 200 mg is indicated for relief of mild to moderate pain in adults and Nalfon 400 mg is indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.

NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.  Nalfon is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.  NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events.

Nalfon is contraindicated in patients who have shown hypersensitivity to fenoprofen calcium.  Nalfon should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients. Nalfon is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. Nalfon is contraindicated in patients with a history of significantly impaired renal function.

FARMINGDALE, NY— January 7, 2010— PEDiNOL Pharmacal Inc. was founded in 1925 by Dr. Harry Goldwag, a podiatrist and esteemed professor of M. Lewi School of Podiatry (now known as the New York College of Podiatric Medicine). PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs.

“We are honored to have been able to serve podiatrists for 85 years,” said Gary Strauss, Chief Executive Officer of PEDiNOL. “The podiatry specialty has played such a vital role in the medical community by diagnosing and treating conditions affecting the foot and ankle. In that aspect, we hope PEDiNOL has helped podiatrists and their patients.”

“We’ve been very fortunate to have the support of the podiatric community for so many years,” stated Richard Strauss, R.Ph., President of PEDiNOL. “It was Dr. Goldwag’s dream to have a pharmaceutical company which focused exclusively on the podiatric specialty. During the past 85 years, we feel we’ve been able to keep his dream alive.”

PEDiNOL is one of the few privately owned specialty pharmaceutical companies in existence. PEDiNOL is currently a corporate sponsor of the American Podiatric Medical Association and the American Podiatric Medical Students Association. We also have a nationwide sales force to provide podiatrists with the most up to date information on PEDiNOL products and support over 40 podiatric educational seminars each year.

For more information regarding PEDiNOL, please visit our newly renovated website at www.pedinol.com.

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY and was founded in the 1920’s by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon® (fenoprofen calcium 200 mg and 400 mg capsules) and Fungoid® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.

FARMINGDALE, NY— December 1, 2009—PEDiNOL Pharmacal Inc. will begin marketing Lactinol HX, a new formulation of the Lactinol brand moisturizers.

Lactinol HX uses the moisturizing power of lactic acid to increase skin water content, debride dead skin cells and promote complete skin health. Unlike PEDiNOL’s popular prescription moisturizer, Lactinol-E Creme, Lactinol HX is available without a prescription.

“We are very excited to offer Lactinol HX to podiatrists and their patients,” states Richard Strauss, R.Ph., President of PEDiNOL. “The Lactinol brand has always represented the highest quality in skin health to the podiatric specialty. Lactinol HX is available without a prescription which will provide podiatric patients with the trusted Lactinol quality without the concerns of drug formulary coverage and costly co-pays.”

PEDiNOL will be providing podiatrists with coupons and samples of Lactinol HX. Patients can purchase Lactinol HX from their local pharmacies and through their podiatrist. To learn more about the newly formulated Lactinol HX and to place an order, please visit PEDiNOL’s website at www.pedinol.com or call PEDiNOL’s toll-free phone number, 1-800-PEDiNOL (733-4665).

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY, and was founded in 1925 by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon^® 200 (fenoprofen calcium 200 mg capsules) and Fungoid^®Tincture (miconazole nitrate 2%).

FARMINGDALE, NY— November 17, 2009—PEDiNOL Pharmacal Inc. is proud to announce the launch of their new and improved website, www.pedinol.com. Visitors to www.pedinol.com can now benefit from improved functionality, including:

• Direct on-line product ordering
• Frequent updates on product news and promotional campaigns
• Improved customer feedback mechanisms
• Current product information and pictures
• In-depth account of PEDiNOL’s long history of service to podiatrists

“We are very excited about PEDiNOL’s new and improved website,” said President of PEDiNOL Richard Strauss, R.Ph. “At PEDiNOL, we have always been focused on serving podiatrists and their patients. The new www.pedinol.com gives us more effective ways to communicate with our customers and provide them with the quality products and service that they deserve.”

To mark this launch, PEDiNOL will be announcing significant price reductions and discount programs. Please visit www.pedinol.com periodically to learn more.

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY and was founded in the 1920’s by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon® (fenoprofen calcium 200 mg and 400 mg capsules) and Fungoid® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.

FARMINGDALE, NY—October 12, 2009—PEDiNOL Pharmacal Inc. announced that it has received FDA approval for Nalfon (fenoprofen calcium) 400mg capsules.  Nalfon 400mg capsules are indicated for the relief of signs and symptoms of rheumatoid arthritis or osteoarthritis in adults with a recommended dose is 400 to 600 mg given orally, 3 or 4 times a day.

Nalfon 400mg capsules offer podiatrists and their patients an improvement in Nalfon’s dosing. One capsule instead of two means there are fewer capsules for the patient to take daily.

“Nalfon 400mg is another wonderful addition to PEDiNOL’s family of podiatry products,” stated Richard Strauss, R.Ph., President of PEDiNOL. “Our mission is to serve podiatrists. We value our customer’s input so when podiatrists asked for a 400mg capsule for improved dosing, we started development on it.”

PEDiNOL plans to launch Nalfon 400mg in early 2010. Nalfon 400mg will be available in 90 count bottles. Nalfon 200mg capsules are also available for dosing flexibility.

Please see a sales representative or www.nalfon.com for full prescribing information.

About PEDiNOL:

Pedinol is based in Farmingdale, NY and was founded in the 1920’s by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon® 200 (fenoprofen calcium 200 mg capsules) and Fungoid® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.

About Nalfon:

Nalfon is indicated for relief of mild to moderate pain in adults and for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.

NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.  Nalfon is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.  NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events.

Nalfon is contraindicated in patients who have shown hypersensitivity to fenoprofen calcium.  Nalfon should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients. Nalfon is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.

Nalfon is contraindicated in patients with a history of significantly impaired renal function.